Valeo Pharma Company Description

Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs.

The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas.

It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and commercialization through all stages.

The company offers access to product specialists and medical information for healthcare professionals and patients.

Valeo Pharma serves healthcare professionals, including Canadian physicians, and focuses on hospital specialty sectors.

The company was founded in 2003 and is based in Kirkland, Canada.

Valeo Pharma Inc.

Country	Canada
Founded	2003
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	110
CEO	Al Moghaddam

Contact Details

Address: 16667 Hymus Boulevard Kirkland, QC H9H 4R9 Canada
Phone	(514) 694-0150
Website	valeopharma.com

Stock Details

Ticker Symbol	VPHIF
Exchange	OTCMKTS
Share Class	Class A Shares
Fiscal Year	November - October
Reporting Currency	CAD
ISIN Number	CA91915B1085
SIC Code	2834

Key Executives

Name	Position
Kyle Steiger	Senior Vice President and Chief Commercial Officer
Pascal Tougas	Chief Financial Officer
Frédéric Dumais	Director of Communications and Investor Relations
Guy-Paul Allard	Vice President of Legal Affairs and Corporate Secretary
Jean Francois Fournier	Head of Ophthalmology Business Unit